iHuman director reports 54,000 option-linked shares
iHuman Inc. director Chi Hanfeng has filed an initial ownership report showing holdings of stock options linked to the company’s Class A ordinary shares.
Rhea-AI Filing Summary
iHuman Inc. director Chi Hanfeng has filed an initial ownership report showing holdings of stock options linked to the company’s Class A ordinary shares. The filing lists options covering 27,000 underlying shares at an exercise price of $0.0500 per share, expiring on November 30, 2030, and another block covering 27,000 underlying shares at the same exercise price, expiring on December 15, 2032.
According to the footnotes, the 2030 options were granted on November 30, 2020 and vested over three years, while the 2032 options were granted on December 15, 2022 and vest in equal annual installments over four years. All holdings are reported as directly owned.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
Footnotes (2)
- F1. These options were granted on November 30, 2020 and vested over a three-year period, with 33.33% of the options vesting on October 8, 2021, 33.33% on October 8, 2022, and the remaining 33.34% on October 8, 2023.
- F2. These options were granted on December 15, 2022 and vest in equal installments over a four-year period, with 25% of the options vest on each anniversary after the grant date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the iHuman (IH) Form 3 filing by Chi Hanfeng report?
What are the exercise prices and expiration dates of Chi Hanfeng’s iHuman options?
How do Chi Hanfeng’s iHuman option grants vest according to the Form 3 footnotes?
Are Chi Hanfeng’s iHuman (IH) option holdings direct or indirect?
AI-generated analysis. How Rhea-AI works. Not financial advice.